These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11016640)

  • 1. CD99 engagement: an effective therapeutic strategy for Ewing tumors.
    Scotlandi K; Baldini N; Cerisano V; Manara MC; Benini S; Serra M; Lollini PL; Nanni P; Nicoletti G; Bernard G; Bernard A; Picci P
    Cancer Res; 2000 Sep; 60(18):5134-42. PubMed ID: 11016640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.
    Sohn HW; Choi EY; Kim SH; Lee IS; Chung DH; Sung UA; Hwang DH; Cho SS; Jun BH; Jang JJ; Chi JG; Park SH
    Am J Pathol; 1998 Dec; 153(6):1937-45. PubMed ID: 9846983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
    Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K
    Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma.
    Scotlandi K; Perdichizzi S; Bernard G; Nicoletti G; Nanni P; Lollini PL; Curti A; Manara MC; Benini S; Bernard A; Picci P
    Eur J Cancer; 2006 Jan; 42(1):91-6. PubMed ID: 16326096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
    Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
    Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary orbital extraskeletal ewing sarcoma.
    Li T; Goldberg RA; Becker B; McCann J
    Arch Ophthalmol; 2003 Jul; 121(7):1049-52. PubMed ID: 12860815
    [No Abstract]   [Full Text] [Related]  

  • 7. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion.
    Hahn JH; Kim MK; Choi EY; Kim SH; Sohn HW; Ham DI; Chung DH; Kim TJ; Lee WJ; Park CK; Ree HJ; Park SH
    J Immunol; 1997 Sep; 159(5):2250-8. PubMed ID: 9278313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIC2 detection in tumors of bone and adjacent soft tissues.
    Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
    Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
    O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
    Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production, characterization, and functional analysis of newly established CD99 monoclonal antibodies MT99/1 and MT99/2.
    Khunkaewla P; Chiampanichayakul S; Yasamut U; Pata S; Kasinrerk W
    Hybridoma (Larchmt); 2007 Aug; 26(4):241-50. PubMed ID: 17725386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engagement of CD99 induces up-regulation of TCR and MHC class I and II molecules on the surface of human thymocytes.
    Choi EY; Park WS; Jung KC; Kim SH; Kim YY; Lee WJ; Park SH
    J Immunol; 1998 Jul; 161(2):749-54. PubMed ID: 9670951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
    Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
    Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis of immature thymocytes mediated by E2/CD99.
    Bernard G; Breittmayer JP; de Matteis M; Trampont P; Hofman P; Senik A; Bernard A
    J Immunol; 1997 Mar; 158(6):2543-50. PubMed ID: 9058785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.
    Nanni P; Landuzzi L; Manara MC; Righi A; Nicoletti G; Cristalli C; Pasello M; Parra A; Carrabotta M; Ferracin M; Palladini A; Ianzano ML; Giusti V; Ruzzi F; Magnani M; Donati DM; Picci P; Lollini PL; Scotlandi K
    Sci Rep; 2019 Aug; 9(1):12174. PubMed ID: 31434953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ewing's sarcoma of the head and neck: a case report].
    Velche-Haag B; Dehesdin D; Proust F; Marie JP; Andrieu-Guitrancourt J; Laquerriere A
    Ann Otolaryngol Chir Cervicofac; 2002 Dec; 119(6):363-8. PubMed ID: 12527847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.
    Gellini M; Ascione A; Flego M; Mallano A; Dupuis ML; Zamboni S; Terrinoni M; D'Alessio V; Manara MC; Scotlandi K; Picci P; Cianfriglia M
    Curr Pharm Biotechnol; 2013; 14(4):449-63. PubMed ID: 22335486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
    Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
    J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.
    Garofalo C; Capristo M; Manara MC; Mancarella C; Landuzzi L; Belfiore A; Lollini PL; Picci P; Scotlandi K
    PLoS One; 2013; 8(12):e83832. PubMed ID: 24391834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.
    Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
    Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramedullary Ewing's sarcoma of the spinal cord associated with hydrocephalus.
    Jia L; Li G; You C; He M; Ye F
    Neurol India; 2009; 57(6):828-9. PubMed ID: 20139532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.